The effect of human chorionic gonadotropin on uterine preparation

The effect of intramuscular injection of human chorionic gonadotropin on uterine preparation in infertile women undergoing in vitro fertilization

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211121053124N1

Enrollment

140

Registered

2021-12-04

Start date

2021-12-22

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility of uterine origin. Female infertility of uterine origin

Interventions

Intervention 1: Intervention group: On the third day of menstruation, endometrial thickness will be measured with ultrasound. If endometrial thickness is appropriate, the person will be treated with e

Eligibility

Sex/Gender

Female

Age

18 Years to 43 Years

Inclusion criteria

Inclusion criteria: Infertile women having at least one grade A or B fetus

Exclusion criteria

Exclusion criteria: Body mass index greater than 30 Male infertility Uterine leiomyoma Endometriosis grade 3, 4 Hydrosalpangitis Withdraw to participation.

Design outcomes

Primary

Measure	Time frame
Biochemical pregnancy. Timepoint: Once, 14 days after fetus transfer. Method of measurement: Blood sampling.;Clinical pregnancy. Timepoint: Once, 6 to 8 weeks after fetus transfer. Method of measurement: Pregnancy sac observation in transvaginal ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Ghasemzadeh

Tehran University of Medical Sciences

dr_fa_ghasemzadeh@yahoo.com+98 21 8608 9089

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026